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The coat color of C57BL/6-Mitf vit/vit mice whitens with age, because of a one-nucleotide mutation in the DNA-
binding region of the microphthalmia-associated transcription factor (MITF), which plays an important role in
melanocyte growth and differentiation. To investigate the signals regulating MITF function, we prepared transgenic
mice expressing three of the external signals that are important for melanocyte development, i.e., hepatocyte
growth factor (HGF), stem cell factor (SCF), and endothelin-3 (ET3), and crossed these mice withMitf vit/vit mice. We
found that the age-dependent coat color whitening of the Mitf vit/vit mice was completely suppressed by the over-
expression of HGF or SCF in the skin, but not by that of ET3. Moreover, HGF, but not ET3, promoted the pro-
liferation of Mitf vit/vit mice-derived melanocytes in culture. These results suggest that the signals from exogenous
HGF and SCF rescued the mi-vitiligo mutation and also that ET3 does not stimulate the common signal trans-
duction pathway for MITF activation shared by HGF and SCF.
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The mutation at the mouse microphthalmia (mi) locus af-
fects the eye size, pigmentation, inner ears, and the ca-
pacity for secondary bone resorption. Homozygous Mitf vit
mutant mice, C57BL/6-Mitf vit/vit, are mildly affected as
compared with those homozygous for other Mitf alleles,
and exhibit a lighter coat color and large white spotting.
With aging, the pigmented areas of these mice become pro-
gressively lighter because of the decrease in the number of
melanocytes in their hair follicles, and become almost com-
pletely white within 6–12 mo (Lerner et al, 1986; Lamoreux
et al, 1992).
The microphthalmia-associated transcription factor
(MITF) contains a basic helix–loop–helix leucine zipper mo-
tif. MITF regulates the expression of enzymes necessary for
pigmentation, such as tyrosinase, tyrosinase-related pro-
teins 1 and 2 (Yasumoto et al, 1994, 1995, 1997, 2002; Fuse
et al, 1996), the melanosomal membrane protein Pmel17/
SILV/GP100 (Du et al, 2003), and the anti-apoptotic factor
BCL2 (McGill et al, 2002). Thus, some of the MITF mutations
lead to the loss of viable melanocytes (Hodgkinson et al,
1993; Hughes et al, 1993).
The Mitf vit/vit mice have a spontaneous mi-vitiligo muta-
tion of MITF in which a G to A transition at bp 793 of the
coding region leads to a D222N substitution (Lamoreux
et al, 1992; Steingrimsson et al, 1994). The mi-vitiligo mutant
protein was shown to have almost the same DNA-binding
activity as compared with that of the wild-type protein;
however, the mutant protein caused progressive death of
the melanocytes (Hemesath et al, 1994).
It is known that hepatocyte growth factor (HGF), stem
cell factor (SCF), and endothelins play essential roles in
melanocyte maintenance. MET, the receptor for HGF, and
KIT, the receptor for SCF, are tyrosine kinase receptors and
have been reported to regulate the proliferation, differenti-
ation, and pigmentation of melanocytes (Matsui et al, 1990;
Matsumoto et al, 1991; Halaban et al, 1992; Wehrle-Haller
and Weston, 1995; Imokawa et al, 1998; Kos et al, 1999).
The endothelins that comprise endothelin -1, -2, and -3
have also been reported to stimulate the proliferation, dif-
ferentiation, and pigmentation of melanocytes (Yada et al,
1991; Lahav et al, 1996; Yoshida et al, 1996; Opdecamp
et al, 1998; Shin et al, 1999); however, the receptors for
endothelins were reported to be G-protein-coupled recep-
tors (Arai et al, 1990; Sakurai et al, 1990). We reported that
transgenic mice expressing HGF, SCF, or endothelin-3 (ET3)
in their epidermal keratinocytes were reported to develop
prominent epidermal pigmentation1 (Kunisada et al, 1998a,
2000). It is considered that the signals of these three factors
regulate the MITF activity and are responsible for the main-
tenance of melanocytes. In fact, KIT was shown to regulate
the MITF function by the phosphorylation of the MITF pro-
tein (Hemesath et al, 1998; Wu et al, 2000).
Here, we aimed at investigating the role of extracellular
signals regulating MITF in vivo by using transgenic mice
This work was carried out at Odawara, Kanagawa, Japan.
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expressing signaling molecules, including SCF, HGF, and
ET3, in their skin. The use of double-mutant mice, obtained
by crossing Mitf vit/vit mice with transgenic mice that singly
expressed these factors, allows one to test the effect of
each factor on the regulation of MITF; therefore, the vitiligo
phenotype, resulting from the cumulative effect of the subtle
defect in Mitf vit/vit, may be altered in response to specifically
modulated signalings induced by these exogenous factors.
Results
Age-dependent modulation of the coat color of Mitf vit/vit
mice expressing growth factor transgenes in their
skin We prepared mice expressing HGF and SCF in the
Mitf vit/vit skin (Mitf vit/vit; HGFTg/þ , and Mitf vit/vit; SCFTg/þ ,
respectively), as described in ‘‘Materials and Methods.’’
Mitfvit/vit mice exhibited a slightly lighter coat color on the
C57BL/6 background at 2 mo after birth (Fig 1D). At the same
age, HGFTg/þ (Fig 1A) and SCFTg/þ (Fig 1B) mice exhibited
darker coat colors with no unpigmented regions and pig-
mented interfollicular skin, including that of the nose and ears.
In double-mutant Mitf vit/vit; HGFTg/þ (Fig 1E) and Mitf vit/vit;
SCFTg/þ (Fig 1F) mice, darkened coat color in the pigmented
skin region and large ventral white spots were observed in all
mice at 2 mo after birth. Along with the progression in age,
Mitf vit/vit mice lose their coat color in regions previously cov-
ered with pigmented hair (Fig 1H ). This progressive whitening
of the coat color, observed in every Mitf vit/vit mouse, however,
was completely suppressed in Mitf vit/vit; HGFTg/þ (Fig 1I ) and
Mitf vit/vit; SCFTg/þ (Fig 1J ) double-mutant mice even after
6 mo. In HGFTg/þ and SCFTg/þ mice, whitening of the coat
color was not observed after 10 mo (data not shown). Thus,
the progressive loss of hair pigmentation observed in ho-
mozygous mi-vitiligo mice was completely suppressed by the
exogenously supplied HGF or SCF in their skin.
ET3Tg/þ mice were also extensively covered with pig-
mented hair, and their interfollicular skin, including that of
the nose and ears, was also heavily pigmented (Fig 1C). The
coat color of Mitf vit/vit; ET3Tg/þ double-mutant mice was
similar to that of Mitf vit/vit; HGFTg/þ , and Mitf vit/vit; SCFTg/þ
mice, i.e., they both exhibited darkened coat color in the
pigmented region and a ventral white spot after 2 mo (Fig
1G). Within 6 mo, however, pigmentation of the dorsal hair
was apparently lost in Mitf vit/vit; ET3Tg/þ mice (Fig 1K ), and
the extent of the progression of coat color whitening was
similar to that in Mitf vit/vit mice (Fig 1H). Clearly, the pro-
gressive loss of hair pigmentation observed in homozygous
mi-vitiligo mice was not prevented by the exogenously sup-
plied ET3.
The color of the non-hairy skin, such as that on the nose
and ears, was different among the different types of double-
mutant mice, i.e., the color of the non-hairy skin of the
Mitf vit/vit; SCFTg/þ mice was darkest and that of the Mitfvit/vit;
HGFTg/þ mice was of almost the same density as that of the
Mitf vit/vit; ET3Tg/þ mice (Fig 1E–G). The color of the non-
hairy skins in these double-transgenic mice, including the
Mitf vit/vit; ET3Tg/þ mice, did not change with age (Fig 1I–K).
Quantitative evaluation of coat color whitening after in-
duced hair regeneration In order to test whether the
suppression of coat color whitening by HGF and SCF
transgenes is directly related to the growth and differenti-
ation of follicular melanocytes, we induced hair regeneration
by plucking. As shown in Fig 2A, the amount of hair melanin
measured at optical density (OD)400 was reduced after
plucking the pigmented hair observed in 4-mo-old Mitfvit/vit
mice. As expected, no significant loss of hair melanin was
observed in Mitf vit/vit; HGFTg/þ , and Mitf vit/vit; SCFTg/þ dou-
ble-mutant mice. In Mitfvit/vit; ET3Tg/þ mice, the loss of hair
melanin was comparable with that of Mitfvit/vit mice after
Figure 1
Coat color changes in the Mitfvit/vit mice by the overexpression of
hepatocyte growth factor (HGF), stem cell factor (SCF), and end-
othelin-3 (ET3). Each growth factor transgene were expressed in
C57BL/6 (A–C) and Mitf vit/vit (D–K) mice. The Mitf vit/vit mice have a
natural ventral white spot (D). The remaining pigmented hair in Mitf vit/vit
mice turned white with aging. The coat color whitening becomes re-
markable at 6 mo (H). In all the three double-mutant mice, i.e., Mitf vit/vit;
HGFTg/þ (E), Mitf vit/vit; SCFTg/þ (F), and Mitfvit/vit; ET3Tg/þ (G), the size
and location of the white spots observed at 2 mo are the same as those
observed in Mitfvit/vit mice. Six months or later, the progress of the coat
color whitening as observed in Mitfvit/vit mice (H) was suppressed
in Mitfvit/vit; HGFTg/þ (I) and Mitfvit/vit; SCFTg/þ (J) mice (photographs in
‘‘H,’’ ‘‘I,’’ and ‘‘J’’ were taken at 6 mo), but no suppression was
observed in Mitfvit/vit; ET3Tg/þ mice at 6 mo (K) or later. MITF, micro-
phthalmia-associated transcription factor.
Figure2
Quantitation of the melanin content in the hair before and after
depilation. (A) The change in the melanin content of hair (OD400/mg) is
demonstrated by the reduction in absorbance before and after the de-
pilation of hair in 4-mo-old mice. None: Mitfvit/vit (N¼21), hepatocyte
growth factor (HGF): Mitfvit/vit; HGFTg/þ (N¼10), stem cell factor (SCF):
Mitfvit/vit; SCFTg/þ (N¼ 10), endothelin 3 (ET3): Mitfvit/vit; ET3Tg/þ (N¼ 9).
Mean  SD, po0.01( t test) compared with the melanin content in
Mitfvit/vit mice. (B) Photographs of the regenerated hair in Mitfvit/vit;
HGFTg/þ (left) and Mitfvit/vit; ET3Tg/þ (right) mice used for quantification
of the melanin content. MITF, microphthalmia-associated transcription
factor; OD, optical density.
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plucking. We also demonstrated the appearance of regen-
erated hair before melanin quantitation in Mitf vit/vit; HGFTg/þ
(Fig 2B, left) and Mitf vit/vit; ET3Tg/þ (Fig 2B, right) mice.
Therefore, the suppression of coat color whitening of ho-
mozygous mi-vitiligo mice by transgenic HGF and SCF is
likely to be attained by promoting melanocyte regeneration
coupled with hair regeneration.
Histological analysis of transgenic Mitf vit/vit mice In or-
der to elucidate whether the suppression or progression of
coat color whitening of Mitf vit/vit; HGFTg/þ , Mitf vit/vit; SCFTg/
þ , and Mitf vit/vit; ET3Tg/þ mice is related to the decrease or
increase in the number of melanocytes, we performed a
histological analysis of the skin of these mutant mice. Two
months after birth, melanocytes were observed in the de-
rmis of Mitf vit/vit; HGFTg/þ mice (Fig 3D), similar to HGFTg/þ
mice (Fig 3A) that we previously reported (Kunisada et al,
2000). The number and location of melanocytes were main-
tained in Mitf vit/vit; HGFTg/þ mice at 4 mo (Fig 3G) and 6 mo
(Fig 3J ) after birth. The melanocytes of SCFTg/þ mice were
observed only in the basal layer of the epidermis (Fig 3B), as
we reported previously (Kunisada et al, 1998a, b). On the
other hand, the melanocytes of Mitf vit/vit; SCFTg/þ mice
were observed not only in the basal layer of the epidermis
but also in dermis (Fig 3E, H, and K). The number of me-
lanocytes in 2-mo-old Mitf vit/vit; SCFTg/þ mice (Fig 3E) was
not less than that in SCFTg/þ mice (Fig 3B), and the number
was still maintained in 4-mo-old (Fig 3H) and 6-mo-old mice
(Fig 3K). In 2-mo-old ET3Tg/þ mice (Fig 3C), numerous me-
lanocytes were observed in the dermis. The number of me-
lanocytes in ET3Tg/þ mice (Fig 3C) was obviously larger
than that in HGFTg/þ and SCFTg/þ mice (Fig 3A and B,
respectively). the number of melanocytes in 2-mo-old Mitf vit/
vit; ET3Tg/þ mice (Fig 3F), however, was obviously smaller
than that in ET3Tg/þ mice (Fig 3C), whereas the location of
the melanocytes Mitf vit/vit; ET3Tg/þ mice was the same as
that in ET3Tg/þ mice (Fig 3C and F). The number of me-
lanocytes in Mitf vit/vit; ET3Tg/þ mice decreased with age (4-
mo-old (Fig 3I) and 6-mo-old (Fig 3L)) and mostly disap-
peared at 6 mo after birth (Fig 3L).
We quantitatively compared the number of interfollicular
melanocytes among three double-mutation mice (Fig 4).
The number of melanocytes in Mitf vit/vit; HGFTg/þ , and
Mitf vit/vit; SCFTg/þ mice remained unchanged from 2 to 6 mo
after birth. In contrast, although the number of melanocytes
in Mitf vit/vit; ET3Tg/þ mice was constantly maintained from 3
wk to 2 mo after birth, a significant decrease was observed
in the number of melanocytes at 4 mo after birth, and few
melanocytes survived until 6 mo. Thus, the gradual loss of
interfollicular melanocytes started as early as 2 mo after
birth in Mitf vit/vit; ET3Tg/þ mice.
To elucidate whether the progressive loss of melanocytes
in the Mitf vit/vit; ET3Tg/þ mice is caused by a sudden de-
crease in the ET3 transgene expression level, we analyzed
the ET3 gene expression level in the Mitf vit/vit; ET3Tg/þ mice
aged 2 and 6 mo by using the quantitative reverse-tran-
scriptase polymerase chain reaction (PCR) method. The
relative ET3 expression levels against glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) in the Mitf vit/vit mice
aged 2 and 6 mo were 0.0011 and 0.0013, respectively, and
those in the Mitf vit/vit; ET3Tg/þ mice aged 2 and 6 mo were
0.30 and 0.21, respectively. At 2 mo of age, the ET3 ex-
pression level in the Mitf vit/vit; ET3Tg/þ mice was clearly
higher than that in the Mitf vit/vit mice, and was even higher at
6 mo of age. These results indicated that the progressive
loss of melanocytes in Mitf vit/vit; ET3Tg/þ mice was not be-
cause of a decrease in the ET3 transgene expression level
with age.
ET3 is not effective for the proliferation ofMitf vit/vit mice-
derived melanocytes in culture In order to elucidate the
effects of ET3 on the proliferation of melanocytes derived
from Mitf vit/vit mice, we compared the number of cells of the
Mitf vit/vit mice-derived melanocytes with those from C57BL/
6 mice 7 d after the cultures were initiated in the presence of
Figure3
Age-dependent changes in the number of melanocytes in the dou-
ble-mutant mice. The double-mutation mice, Mitfvit/vit; HGFTg/þ ,
Mitfvit/vit; SCFTg/þ , and Mitfvit/vit; ET3Tg/þ , were generated by crossing
the C57BL/6-HGFTg/þ , C57BL/6-SCFTg/þ , and C57BL/6-ET3Tg/þ
transgenic mice with Mitfvit/vit. Hematoxylin and eosin-stained sections
of 2-mo-old HGFTg/þ (A), SCFTg/þ (B), and ET3Tg/þ (C) mice revealed
pigmented melanocytes in the dermis (HGFTg/þ (A) and ET3Tg/þ (C)) or
the epidermis (SCFTg/þ (B)). The number of pigmented melanocytes in
ET3Tg/þ (C) mice was apparently more than that in HGFTg/þ (A) and
SCFTg/þ (B) mice. The melanocytes in 2-mo-old Mitfvit/vit; HGFTg/þ
mice (D) were located around hair follicles, similar to HGFTg/þ mice of
the same age (A). The melanocytes in 2-mo-old Mitfvit/vit; SCFTg/þ mice
(E) were observed not only in the basal layer of the epidermis but also in
the dermis, unlike in SCFTg/þ mice of the same age (B). The me-
lanocytes in 2-mo-old Mitfvit/vit; ET3Tg/þ mice (F) were observed in the
dermis, but the number was less than that in ET3Tg/þ mice of the same
age (C). The sections of 4- and 6-mo-old Mitfvit/vit; HGFTg/þ (G and J,
respectively), Mitfvit/vit; SCFTg/þ (H and K, respectively), and Mitfvit/vit;
ET3Tg/þ (I and L, respectively) mice skins were also indicated. The
number and location of the melanocytes in Mitfvit/vit; HGFTg/þ (D, G,
and J), Mitfvit/vit; SCFTg/þ (E, H, and K) mice were stably maintained
through 6 mo of age. The number of melanocytes in Mitfvit/vit; ET3Tg/þ
mice decreased with age (F, I, and L) and mostly disappeared at 6 mo
after birth (L). Arrowheads indicate the pigmented melanocytes in each
figure. Scale bar¼50 mm. MITF, microphthalmia-associated transcrip-
tion factor; HGF, hepatocyte growth factor; SCF, stem cell factor; ET3,
endothelin 3.
540 KURITA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
ET3 (Fig 5). The number of C57BL/6 mice-derived me-
lanocytes significantly increased in the culture with ET3, and
did not change in the culture with HGF. In contrast, the
number of Mitf vit/vit mice-derived melanocytes was not af-
fected in the presence of ET3; instead, significant prolifer-
ation was observed in the culture supplemented with HGF.
Thus, it is conceivable that reduction in the melanocytes
in Mitf vit/vit; ET3Tg/þ skin (Fig 3F) compared with numerous
melanocytes in ET3Tg/þ skin (Fig 3C) implies the lack of
stimulatory effect of exogenous ET3 produced in the skin on
the melanocytes with Mitf vit/vit genetic background.
Discussion
The dependence of melanocyte development on MITF is
obvious in the loss-of-function mutants of the Mitf gene.
Forced expression of MITF in Swiss NIH3T3 cells is known
to induce differentiation of this cell line into melanocyte lin-
eages (Tachibana et al, 1996).
Our results demonstrate that the progressive coat color
whitening of Mitf vit/vit mice was suppressed by the over-
expression of SCF or HGF in their skin, both of which are
known to be growth and differentiation factors for me-
lanocytes. It was reported that SCF signaling, through its
receptor KIT tyrosine kinase, finally triggers MITF activation
via the mitogen-activated protein kinase/extracellular sig-
nal-regulated kinase-mediated phosphorylation of Ser73
and via the p90 Rsk-1-mediated phosphorylation of Ser409
of the MITF protein (Hemesath et al, 1998; Wu et al, 2000).
On the other hand, it was not known whether HGF signaling
by MET receptor tyrosine kinase also activates MITF. Based
on our genetic analysis, we believe that it is likely that HGF
signaling activates the proliferation of melanocytes through
MITF stimulation.
It was clear that the mi-vitiligo mutation, D222N, affects
coat color whitening with age, but the mi-vitiligo mutant
protein did not have a measurable effect on the DNA-bind-
ing activity, the production of homodimer, and the produc-
tion of the heterodimeric complex with TFE3 or TFEB, the
basic helix-loop-helix zipper type transcription factors
(Hemasath et al, 1994). This suggested two possibilities.
First, a small difference in the DNA-binding activities be-
cause of mi-vitiligo mutation was sufficient to induce the
age-dependent whitening of coat color. Second, the mod-
ulation of the tetrameric forms with TFE3 or TFEB because
of mi-vitiligo mutation prevented the DNA binding. We be-
lieve that the induction of MITF phosphorylation by the
overexpression of HGF or SCF resulted in the recovery of
the DNA-binding activities of the mi-vitiligo mutant protein
and rescued the progressive loss of melanocytes in the
Mitf vit/vit mice.
On the other hand, overexpression of ET3 in the skin did
not rescue the mice from this mi-vitiligo phenotypic defect. It
is known that all the three endothelins, ET1, ET2, and ET3,
stimulate the generation of melanoblasts from neural crest
cells (Opdecamp et al, 1998; Shin et al, 1999). It is clear that
ET3 could stimulate the development of the melanocyte
lineage, because the extent of pigmentation observed in the
transgenic skin and hair was not less than that observed in
HGF and SCF transgenic mice (Fig 3A–C). On the other
hand, our histological analysis demonstrated that the
Figure 4
Measurement of the number of pigmented interfollicular me-
lanocytes in the double-mutant mice. At 2 mo of age, the number
of pigmented interfollicular melanocytes in Mitf vit/vit; SCFTg/þ mice (E)
was more than that in Mitf vit/vit; HGFTg/þ (’) and in Mitf vit/vit; ET3Tg/þ
(m) mice. The number of melanocytes in Mitf vit/vit; HGFTg/þ and Mitf vit/vit;
SCFTg/þ mice was maintained through 6 mo of age, but that of Mitf vit/vit;
ET3Tg/þ was continuously decreased after 4 mo of age. Mean  SD,
 po0.01 (t test) compared with each 2-mo-old mice. MITF, micro-
phthalmia-associated transcription factor; HGF, hepatocyte growth
factor; SCF, stem cell factor; ET3, endothelin 3.
Figure 5
Effects of growth factors on the maintenance of melanocytes derived from C57BL/6 and Mitf vit/vit mice. The number of melanocytes derived
from C57BL/6 (A) or Mitf vit/vit (B) mice after 7 d of culture with hepatocyte growth factor (HGF) or endothelin-3 (ET3) was indicated. ET3 increased
the number of C57BL/6-derived melanocytes in culture, but not that of Mitf vit/vit-derived melanocytes. Proliferative effect of HGF was observed in
Mitf vit/vit-derived melanocytes. Mean  SD, po0.05 (t test) compared with corresponding control.
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number of melanocytes in the skin of Mitf vit/vit; ET3Tg/þ
mice was obviously less than that of ET3Tg/þ mice at just 2
mo after birth (Fig 3C and F). Moreover, these melanocytes
in Mitf vit/vit; ET3Tg/þ mice were not maintained with age and
lead to the coat color whitening in Mitf vit/vit; ET3Tg/þ mice to
the same extent as that in Mitf vit/vit mice. We also showed
that the ET3 expression level in the Mitf vit/vit; ET3Tg/þ mice
was several 100-fold higher than that in the Mitf vit/vit mice,
and the level was maintained until the age of 6 mo. Appar-
ently, the overexpression of ET3 was unable to rescue the
progressive loss of melanocytes that occurred because of
mi-vitiligo mutation.
These in vivo observations were supported by the in vitro
proliferation assay using the Mitf vit/vit mice-derived me-
lanocytes. It was demonstrated that ET3 promoted the pro-
liferation of the C57BL/6 mice-derived melanocytes in
culture, but not Mitf vit/vit mice-derived melanocytes (Fig 5).
In contrast, the addition of HGF increased the number of the
Mitf vit/vit mice-derived melanocytes (Fig 5). It has been ob-
served that HGF induces the proliferation of normal epider-
mal melanocytes (Matsumoto et al, 1991); an increase in the
melanocytes in the skin of HGFTg/þ mice was observed
(Kunisada et al, 2000). This indicated that HGF was an in-
ducer of melanocyte proliferation. Our results, however,
showed that HGF promoted the proliferation of melanocytes
that were derived from Mitf vit/vit mice, but not of those de-
rived from C57BL/6 mice. It was suggested that the effect of
HGF in inducing melanocyte proliferation was prominent in
more stringent medium. In fact, HGF was shown to induce
melanocyte proliferation in bovine pituitary extract-free me-
lanocyte growth medium (Matsumoto et al, 1991). We be-
lieved that the limited effect of HGF on the melanocytes
from C57BL/6 mice observed in this study was because of
the coculture of melanocytes with keratinocytes in a nutri-
ent-rich medium—Dulbecco’s modified eagle’s medium
(DMEM) supplemented with 15% fetal bovine serum
(FBS). In contrast, melanocytes from Mitfvit/vit mice were
stimulated by HGF. This cannot be explained well with the
available information. But there is a possibility that the in-
duction of the MITF phosphorylation by HGF rescued the
mi-vitiligo mutation; this rescued MITF acts differently when
compared with the normal MITF. The melanocytes from the
Mitfvit/vit mice were able to proliferate in DMEM supple-
mented with 15% FBS. Nevertheless, our results showed
that ET3 did not induce the melanocyte proliferation in the
Mitfvit/vit mice. It was suggested that the mi-vitiligo mutation
was crucial for the signaling of ET3 through its G-protein-
coupled receptor, Endothelin receptor B, and acts differ-
ently from that of SCF and HGF. Although the precise
signaling pathways that start from ET3 have not been re-
vealed completely, the mi-vitiligo mutation may provide the
key to a more complete understanding of the signals reg-
ulating the biological function of MITF.
It was demonstrated that MITF regulated the transcrip-
tion of anti-apoptotic BCL2 and the BCL2þ /; Mitfvit/þ dou-
ble heterozygote mutant mice exhibited an age-related
whitening of coat color similar to that exhibited by the
Mitfvit/vit homozygote mice (McGill et al, 2002). Interestingly,
they mentioned that the survival of melanocytes from KIT-
deficient mice was not affected by the transgenic expres-
sion of BCL2. This suggests that receptors of tyrosine kin-
ases act independent of the BCL2 expression to rescue the
MITF defect. Based on our observation, it is predicted that
the overexpression of SCF and HGF may rescue the age-
related whitening phenotype of BCL2 and mi-vitiligo double
heterozygotes mutant mice.
Recently, patients receiving an oral tyrosine kinase in-
hibitor which targets the KIT receptor as well as other kinase
receptors (Abrams et al, 2003) exhibited loss of hair pig-
mentation which recovered in the intervals between drug
treatment (Moss et al, 2003). These observations indicate
that the loss of MITF activity, possibly induced by the in-
hibition of KIT signaling, leads to the loss of hair pigmen-
tation in humans. Moreover, the mutations of MITF, the
human homologue of mouse Mitf, occur in patients with
Waardenburg syndrome type 2, a disorder associated with
melanocyte abnormalities, including those of head hair
(Waardenburg, 1951; Tassabehji et al, 1994, 1995; Nobukuni
et al, 1996). Based on these observations in humans and
this experiment on mice, it is conceivable that graying of
hair in humans may be because of the age-dependent at-
tenuation of DNA-binding abilities of MITF. Earlier, we con-
firmed the existence of melanocytes in the outer root sheath
of gray hair in humans (Takada et al, 1992). Repigmentation
of gray hair might be attained through the proliferation of the
remaining melanocytes or their progenitors in the outer root
sheath through MITF activation.
Materials and Methods
Animals Mitfvit/vit mice were obtained from the Jackson Labora-
tory (Bar Harbor, Maine). Transgenic HGF, SCF, and ET3 mice were
prepared in our laboratory (Kunisada et al, 1998a, 2000). In brief,
the complementary DNA of each growth factor were cloned into
constructs containing the human cytokeratin 14 upstream region,
rabbit b-globin intron, and poly(A) signal of human cytokeratin 14
and injected into fertilized oocytes. Mitfvit/vit and heterozygous
HGF, SCF, and ET3 transgenic mice were crossed to obtain dou-
ble-mutant mice, i.e., Mitfvit/þ ; HGFTg/þ , Mitfvit/þ ; SCFTg/þ , and
Mitfvit/þ ; ET3Tg/þ , respectively. These transgenic mice were further
crossed to produce double-mutant mice with the Mitfvit/vit geno-
type. Double-mutant mice, with Mitfvit/vit expressing each growth
factor transgene, were identified as mice with large white spots
that are characteristic of Mitfvit homozygotes, and pigmented nose
and ears that resulted from the action of each growth factor trans-
gene. All experiments were performed in accordance with the
Guide for the Care and Use of Laboratory Animals of LION Cor-
poration, Japan.
Evaluation of suppression of hair graying and measurement of
hair melanin The pelages of the double-mutant mice were
plucked at 4 mo after birth to force regeneration. This manipula-
tion turned the coat color of Mitfvit/vit mice into gray, earlier than the
normal 6 mo after birth. The amount of hair melanin was measured
as OD400 per mg of the hair after overnight digestion with protease
Esperase 8.0L (SIGMA, St Louis, Missouri) at 371C.
Counts of the interfollicular melanocytes in the transgenic
mice We prepared the 8 mm cryosections of the mouse skin,
hematoxylin and eosin stained, and counted the number of pig-
mented melanocytes in interfollicular dermal skin.
Quantitative real-time PCR Real-time PCR was performed using
a GeneAmp 5700 sequence detection system (Applied Biosys-
tems, Foster City, California). The reactions were performed using
SYBR Green PCR Master Mix (Applied Biosystems). The PCR
cycling conditions were as follows: 951C for 10 min, 40 cycles at
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941C for 15 s, and 601C for 1 min. The following primers were
used: GAPDH: TTGTCAAGCTCATTTCCTGGTATG and TCCACCA-
CCCTGTTGCTGTA, and ET3: CGAGCTTACTGTGAGTGTGGAGA-
TG and CCCACTCAAATGCCGTTTCC.
Culture of the melanocytes derived from C57BL/6 and Mitfvit/vit
mice Dorsal skins of 2-mo-old C57BL/6 and Mitfvit/vit mice were
dissected 3 d after depilation, in order to activate the proliferation
of hair follicular melanocytes by facilitating the entry of the anagen
phase of the hair cycle. The obtained skins were cut into small
pieces and incubated in a 0.5% trypsin solution (Invitrogen, Car-
lsbad, California) for 6 h at 41C, followed by 371C for 15 min. The
skins were cut more finely and repeatedly pipetted. In order to
remove the debris, they were filtered with a 40 mm pore-size filter
(Becton Dickinson, Franklin Lakes, New Jersey). The filtered cells
were pelleted by centrifugation for 5 min at 170  g. The collected
cells were re-suspended in DMEM (Sigma, St Louis, Missouri)
containing 15% fetal bovine serum (Invitrogen, Carlsbad, Califor-
nia) and plated equally onto the culture dishes (Sumitomo Bakelite,
Tokyo, Japan). The plated dishes were divided into three groups.
HGF (PeproTech, Rocky Hill, New Jersey) was added to the first
group, ET3 (Sigma) was added to the second group, and phos-
phate-buffered saline was added as a negative control to the third
group. The culture medium supplemented with each growth factor
was first changed 24 h after the culture was started; subsequently,
it was changed every 2 d.
Immunohistochemistry for cultured cells After 7 d of culture,
the melanocytes of each group were immunohistochemically de-
tected. The cells were fixed by 1% acetic acid/99% ethanol at 41C
for 10 min, and were incubated for 60 min at 41C by the blocking
solution, that is, 1% skim milk (Becton Dickinson, Franklin Lakes,
New Jersey) in tris-buffered saline. They were incubated overnight
at 41C with the primary antibody of anti-PEP8 (provided by Dr
Vincent J Hearing), which recognized tyrosinase-related protein 2
as the melanocyte-specific protein. Subsequently, they were incu-
bated with an anti-rabbit immunoglobulin G antibody/horse radish
peroxidase (HRP)-conjugated (Santa Cruz Biotechnology, Santa
Cruz, California) as a secondary antibody, for 3 h at room temper-
ature. The HRP-conjugated secondary antibody was visualized
using the AEC Peroxidase Substrate Kit (Vector Laboratories,
Burlingame, California). Control experiments without primary anti-
bodies were carried out for each of the antibodies tested.
We would like to thank Dr Vincent J. Hearing (Laboratory of Cell
Biology, National Cancer Institute, National Institutes of Health) for
providing us with anti-PEP8.
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